MARKET

NRXP

NRXP

Nrx Pharmaceuticals Inc
NASDAQ
3.178
-0.162
-4.84%
Opening 09:37 08/14 EDT
OPEN
3.370
PREV CLOSE
3.340
HIGH
3.400
LOW
3.155
VOLUME
270.42K
TURNOVER
--
52 WEEK HIGH
5.06
52 WEEK LOW
1.620
MARKET CAP
115.15M
P/E (TTM)
-2.4889
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at NRXP last week (0803-0807)?
Weekly Report · 4d ago
NRx Pharmaceuticals To Host Conference Call And Q&A Session On August 10 To Discuss FDA's Completion Of First-Cycle Review Of Its ANDA For Preservative-Free Ketamine
Benzinga · 6d ago
NRX Pharmaceuticals Is Maintained at Buy by BTIG
Dow Jones · 6d ago
NRX Pharmaceuticals Price Target Cut to $10.00/Share From $25.00 by BTIG
Dow Jones · 6d ago
BTIG Maintains Buy on NRX Pharmaceuticals, Lowers Price Target to $10
Benzinga · 6d ago
NRx Pharma rises as FDA completes initial review of ketamine product
Seeking Alpha · 6d ago
Analysts’ Opinions Are Mixed on These Healthcare Stocks: NRX Pharmaceuticals (NRXP), Novo Nordisk (NVO) and Pfizer (PFE)
TipRanks · 6d ago
NRx Pharmaceuticals Shares Rise After FDA Finishes Ketamine Review
Dow Jones · 6d ago
More
About NRXP
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing therapeutics based on its N-methyl-D-aspartate (NMDA) platform for the treatment of central nervous system disorders, specifically suicidal depression, chronic pain, and PTSD. It is developing NRX-100 (preservative-free intravenous ketamine) and NRX-101, (oral D-cycloserine/lurasidone). NRX-100 has been awarded Fast Track Designation for the treatment of Suicidal Ideation in Depression, including Bipolar Depression. NRX-101 has been awarded Breakthrough Therapy Designation for the treatment of suicidal bipolar depression. NRx has filed an Abbreviated New Drug Application (ANDA) and initiated a New Drug Application filing for NRX-100 (IV ketamine) with an application for the Commissioner’s National Priority Voucher Program for the treatment of suicidal depression. Its subsidiary, HOPE Therapeutics, Inc., is a healthcare delivery company that is building a network of interventional psychiatry clinics.

Webull offers NRX Pharmaceuticals Inc stock information, including NASDAQ: NRXP real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NRXP stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NRXP stock methods without spending real money on the virtual paper trading platform.